Tetracycline + Trastuzumab And Hyaluronidase Oysk Interaction
Majorinteraction on record
Description
Patients receiving anthracyclines after stopping HERCEPTIN HYLECTA may have increased risk of cardiac dysfunction due to long washout period. Avoid anthracycline-based therapy for up to 7 months after stopping; if used, closely monitor cardiac function.
Mechanism
Long washout period of HERCEPTIN HYLECTA increases cumulative cardiotoxicity risk
Source: NLP:trastuzumab and hyaluronidase-oysk